| Product Name | Tosatoxumab |
|---|---|
| CAS | 1374419-41-6 |
| Storage condition | Store at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light. |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 1 mg | 3-5days | $720.00 | Visible after login | |
| 5 mg | 3-5days | $1600.00 | Visible after login | |
| 10 mg | 3-5days | $2900.00 | Visible after login | |
| 50 mg | 3-5days | $12000.00 | Visible after login | |
| 100 mg | 3-5days | $18000.00 | Visible after login |
| Product Name | Tosatoxumab |
|---|---|
| CAS | 1374419-41-6 |
| Storage condition | Store at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light. |
Tosatoxumab (AR-301; KBSA301) is a human immunoglobulin G1 monoclonal antibody that specifically neutralizes alpha-toxin (alpha-hemolysin; Hla) of S. aureus . Tosatoxumab binds to an N-terminal epitope of alpha-toxin, thereby preventing functional toxin pore oligomerisation. Tosatoxumab has the potential for passive immunotherapy in the S. aureus pneumonia as an adjunctive therapy to standard antibiotic agent.